Literature DB >> 7594675

Influenza A virus--induced acute otitis media.

C A Buchman1, W J Doyle, D P Skoner, J C Post, C M Alper, J T Seroky, K Anderson, R A Preston, F G Hayden, P Fireman.   

Abstract

To better understand the significance of viral upper respiratory tract infections in the pathogenesis of acute otitis media (OM), 27 adults underwent intranasal inoculation with influenza A virus. Monitoring consisted of antibody titer determination, tympanometry, and otoscopy. Microbiologic analysis consisted of cultures and polymerase chain reaction (PCR)-based detection for influenza A virus, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. All subjects became infected with the challenge virus. By day 4, 16 (59%) developed middle ear pressures of -100 mm H2O or below and 4 (25%) of them developed OM. One subject (4%) developed purulent OM requiring myringotomy for pain relief. Middle ear effusion cultures were negative. PCR analysis of that subject's middle ear effusion and nasal washes were positive for influenza A virus and S. pneumoniae. These findings support a causal role for viral upper respiratory tract infections in the pathogenesis of OM, possibly mediated by middle ear underpressures and viral and bacterial middle ear infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594675     DOI: 10.1093/infdis/172.5.1348

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Influenza virus induces bacterial and nonbacterial otitis media.

Authors:  Kirsty R Short; Dimitri A Diavatopoulos; Ruth Thornton; John Pedersen; Richard A Strugnell; Andrew K Wise; Patrick C Reading; Odilia L Wijburg
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

2.  Oseltamivir treatment for acute otitis media in children with influenza.

Authors:  David P Skoner
Journal:  Curr Allergy Asthma Rep       Date:  2010-11       Impact factor: 4.806

3.  Influenza A virus alters pneumococcal nasal colonization and middle ear infection independently of phase variation.

Authors:  John T Wren; Lance K Blevins; Bing Pang; Lauren B King; Antonia C Perez; Kyle A Murrah; Jennifer L Reimche; Martha A Alexander-Miller; W Edward Swords
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

4.  A formal description of middle ear pressure-regulation.

Authors:  William J Doyle
Journal:  Hear Res       Date:  2017-08-24       Impact factor: 3.208

Review 5.  Evolving role of leukotrienes in the pathogenesis of viral infections, including otitis media.

Authors:  Deborah Gentile
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

6.  Pro-inflammatory interleukins in middle ear effusions from atopic and non-atopic children with chronic otitis media with effusion.

Authors:  Beata Zielnik-Jurkiewicz; Wanda Stankiewicz-Szymczak
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-16       Impact factor: 2.503

7.  Polymerase Chain Reaction (PCR) Versus Bacterial Culture in Detection of Organisms in Otitis Media with Effusion (OME) in Children.

Authors:  Balegh H Aly; Mostafa S Hamad; Mervat Mohey; Sameh Amen
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-03-01

8.  Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by influenza A virus and Streptococcus pneumoniae opacity variants.

Authors:  H H Tong; J P Long; P A Shannon; T F DeMaria
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

Review 9.  Importance of respiratory viruses in acute otitis media.

Authors:  Terho Heikkinen; Tasnee Chonmaitree
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

10.  Comparison of alteration of cell surface carbohydrates of the chinchilla tubotympanum and colonial opacity phenotype of Streptococcus pneumoniae during experimental pneumococcal otitis media with or without an antecedent influenza A virus infection.

Authors:  H H Tong; I Grants; X Liu; T F DeMaria
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.